About this trial
This pilot study is testing a new ultrasound imaging method called Super-Resolution Ultrasound (SRU) to look at blood flow and tiny blood vessels in transplanted kidneys in very detailed images after kidney transplant surgery. The goal is to see whether changes in the kidney's small blood vessels can help predict how well the transplanted kidney will work early after transplant, including whether delayed graft function may occur.
Investigators hope this technique can become a safe, noninvasive way to evaluate transplanted kidneys without needing as many invasive biopsies. It may also help doctors better assess donor kidneys at higher-risk of suboptimal functioning.
Eligibility criteria
Qualifiers
We will enroll patients ≥18 years of age
Patients who received a kidney transplant 2a. Patients requiring dialysis in the first 14 days after transplant 2b. Patients with working allografts not requiring dialysis (control group)
We will enroll patients at least 18 years of age or older
Patients who received a kidney transplant 2a. Patients who received kidney transplants from low KDPI kidneys (KDPI < 35) 2b. Patients who received kidney transplants from high KDPI kidneys (KDPI > 75)
Disqualifiers
BMI > 40
Inability to provide informed consent
Pregnant woman
Breastfeeding women
Trial design
Treatments tested in this trial
- Ultrasound contrast agent (Contrast-enhanced ultrasound)
- Optison (Perflutren Protein-Type A Microspheres Injectable Suspension)
- Lumason® contrast agent
- DEFINITY®
Treatment groups
Sponsors and collaborators
Roderick Tan
Lead sponsor
University of Pittsburgh
Sponsor institution